Last reviewed · How we verify
NCT07023900
Lead Extraction With Manual Traction
trial testing Manual traction in Pacemaker Lead Dysfunction in 130 participants. Completed in 1 May 2023.
1 December 2021
Quick facts
| Lead sponsor | Bursa Postgraduate Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 1 January 2016 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 May 2023 |
Drugs / interventions tested
- Manual traction
Conditions studied
- Pacemaker Lead Dysfunction — all drugs for Pacemaker Lead Dysfunction →
- Manual Traction — all drugs for Manual Traction →
Sponsor
Bursa Postgraduate Hospital
Who can join
Eligibility, any sex, with Pacemaker Lead Dysfunction or Manual Traction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The number of implantable cardiac rhythm devices is increasing. As a result, the number of patients requiring lead extraction is increasing. In this study, authors aimed to present their experience with lead extraction using manual traction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07023900
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Bursa Postgraduate Hospital trials
Trials by the same sponsor.
- NCT07129122 — A Novel Technique for Percutaneous Mitral Paravalvular Leak Closure: LBBAP Lead Assisted Ventricular Septal Way · completed
- NCT06878638 — Nitrate - Clopidogrel - Acute Coronary Syndrome · completed
- NCT06951737 — Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients · completed
- NCT05541757 — Rivaroxaban - Percutaneous Coronary Intervention · completed
- NCT04507282 — Eosinophil and Anticoagulation in COVID-19 Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07023900 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bursa Postgraduate Hospital
- Last refreshed: 17 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07023900.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing